These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33442579)

  • 1. Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory Science.
    Stephenson D; Alexander R; Aggarwal V; Badawy R; Bain L; Bhatnagar R; Bloem BR; Boroojerdi B; Burton J; Cedarbaum JM; Cosman J; Dexter DT; Dockendorf M; Dorsey ER; Dowling AV; Evers LJW; Fisher K; Frasier M; Garcia-Gancedo L; Goldsack JC; Hill D; Hitchcock J; Hu MT; Lawton MP; Lee SJ; Lindemann M; Marek K; Mehrotra N; Meinders MJ; Minchik M; Oliva L; Romero K; Roussos G; Rubens R; Sadar S; Scheeren J; Sengoku E; Simuni T; Stebbins G; Taylor KI; Yang B; Zach N
    Digit Biomark; 2020; 4(Suppl 1):28-49. PubMed ID: 33442579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital technologies: Innovations that transform the face of drug development.
    Izmailova ES; AbuAsal B; Hassan HE; Saha A; Stephenson D
    Clin Transl Sci; 2023 Aug; 16(8):1323-1330. PubMed ID: 37157935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective.
    Stephenson D; Badawy R; Mathur S; Tome M; Rochester L
    J Parkinsons Dis; 2021; 11(s1):S103-S109. PubMed ID: 33579873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A roadmap for implementation of patient-centered digital outcome measures in Parkinson's disease obtained using mobile health technologies.
    Espay AJ; Hausdorff JM; Sánchez-Ferro Á; Klucken J; Merola A; Bonato P; Paul SS; Horak FB; Vizcarra JA; Mestre TA; Reilmann R; Nieuwboer A; Dorsey ER; Rochester L; Bloem BR; Maetzler W;
    Mov Disord; 2019 May; 34(5):657-663. PubMed ID: 30901495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empowering drug development: Leveraging insights from imaging technologies to enable the advancement of digital health technologies.
    Izmailova ES; Maguire RP; McCarthy TJ; Müller MLTM; Murphy P; Stephenson D
    Clin Transl Sci; 2023 Mar; 16(3):383-397. PubMed ID: 36382716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson's Disease.
    Stephenson D; Hu MT; Romero K; Breen K; Burn D; Ben-Shlomo Y; Bhattaram A; Isaac M; Venuto C; Kubota K; Little MA; Friend S; Lovestone S; Morris HR; Grosset D; Sutherland M; Gallacher J; Williams-Gray C; Bain LJ; Avilés E; Marek K; Toga AW; Stark Y; Forrest Gordon M; Ford S
    J Parkinsons Dis; 2015; 5(3):581-94. PubMed ID: 26406139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital Health Technology to Measure Drug Efficacy in Clinical Trials for Parkinson's Disease: A Regulatory Perspective.
    Sacks L; Kunkoski E
    J Parkinsons Dis; 2021; 11(s1):S111-S115. PubMed ID: 33459666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved measurement of disease progression in people living with early Parkinson's disease using digital health technologies.
    Czech MD; Badley D; Yang L; Shen J; Crouthamel M; Kangarloo T; Dorsey ER; Adams JL; Cosman JD
    Commun Med (Lond); 2024 Mar; 4(1):49. PubMed ID: 38491176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Session Introduction: Digital health technology data in biocomputing: Research efforts and considerations for expanding access (PSB2024).
    Holko M; Lunt C; Dunn J
    Pac Symp Biocomput; 2024; 29():163-169. PubMed ID: 38160277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial.
    Lipsmeier F; Taylor KI; Kilchenmann T; Wolf D; Scotland A; Schjodt-Eriksen J; Cheng WY; Fernandez-Garcia I; Siebourg-Polster J; Jin L; Soto J; Verselis L; Boess F; Koller M; Grundman M; Monsch AU; Postuma RB; Ghosh A; Kremer T; Czech C; Gossens C; Lindemann M
    Mov Disord; 2018 Aug; 33(8):1287-1297. PubMed ID: 29701258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Australia in 2030: what is our path to health for all?
    Backholer K; Baum F; Finlay SM; Friel S; Giles-Corti B; Jones A; Patrick R; Shill J; Townsend B; Armstrong F; Baker P; Bowen K; Browne J; Büsst C; Butt A; Canuto K; Canuto K; Capon A; Corben K; Daube M; Goldfeld S; Grenfell R; Gunn L; Harris P; Horton K; Keane L; Lacy-Nichols J; Lo SN; Lovett RW; Lowe M; Martin JE; Neal N; Peeters A; Pettman T; Thoms A; Thow AMT; Timperio A; Williams C; Wright A; Zapata-Diomedi B; Demaio S
    Med J Aust; 2021 May; 214 Suppl 8():S5-S40. PubMed ID: 33934362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation of Digital Health Technologies to Advance Precision Medicine: Informing Regulatory Science.
    Adamo JE; Bienvenu Ii RV; Dolz F; Liebman M; Nilsen W; Steele SJ
    Digit Biomark; 2020; 4(1):1-12. PubMed ID: 32399511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Session Introduction: Digital health technology data in biocomputing: Research efforts and considerations for expanding access.
    Holko M; Lunt C; Dunn J
    Pac Symp Biocomput; 2023; 28():1-6. PubMed ID: 36540959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving Cardiovascular Drug and Device Development and Evidence Through Patient-Centered Research and Clinical Trials: A Call to Action From the Value in Healthcare Initiative's Partnering With Regulators Learning Collaborative.
    Warner JJ; Crook HL; Whelan KM; Bleser WK; Roiland RA; Hamilton Lopez M; Saunders RS; Wang TY; Hernandez AF; McClellan MB; Califf RM; Brown N;
    Circ Cardiovasc Qual Outcomes; 2020 Jul; 13(7):e006606. PubMed ID: 32683985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Roadmap to Inform Development, Validation and Approval of Digital Mobility Outcomes: The Mobilise-D Approach.
    Rochester L; Mazzà C; Mueller A; Caulfield B; McCarthy M; Becker C; Miller R; Piraino P; Viceconti M; Dartee WP; Garcia-Aymerich J; Aydemir AA; Vereijken B; Arnera V; Ammour N; Jackson M; Hache T; Roubenoff R
    Digit Biomark; 2020; 4(Suppl 1):13-27. PubMed ID: 33442578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital health technology for non-motor symptoms in people with Parkinson's disease: Futile or future?
    van Wamelen DJ; Sringean J; Trivedi D; Carroll CB; Schrag AE; Odin P; Antonini A; Bloem BR; Bhidayasiri R; Chaudhuri KR;
    Parkinsonism Relat Disord; 2021 Aug; 89():186-194. PubMed ID: 34362670
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.